RegisterLogin

ML327

CAT: 0804-HY-103038-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-103038-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
ML327 is a blocker of MYC which can also de-repress E-cadherin transcription and reverse Epithelial-to-Mesenchymal Transition (EMT) .
CAS Number
[1883510-31-3]
UNSPSC
12352005
Hazard Statement
H302
Target
Autophagy; c-Myc
Type
Reference compound
Related Pathways
Apoptosis; Autophagy
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ML327.html
Purity
98.02
Solubility
DMSO : 32 mg/mL (ultrasonic; warming)
Smiles
O=C(C1=CC=CNC1=O)NCCCNC(C2=NOC(C3=CC=CC=C3)=C2)=O
Molecular Formula
C19H18N4O4
Molecular Weight
366.37
Precautions
H302
References & Citations
[1]Rellinger EJ, et al. Isoxazole compound ML327 blocks MYC expression and tumor formation in neuroblastoma. Oncotarget. 2017 Jul 20;8 (53) :91040-91051.|[2]An H, et al. Small molecule/ML327 mediated transcriptional de-repression of E-cadherin and inhibition of epithelial-to-mesenchymal transition.Oncotarget. 2015 Sep 8;6 (26) :22934-48.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-16636-01ML337
HY-157728-01ML307
HY-122904ML377
HY-101464-01ML329
HY-124713-01ML372
HY-12274-01ML347
HY-12725-01ML324
HY-122198-01ML367
HY-136638-01ML328
HY-101464RML329 (Standard)

Alternative Products

CatalogName
456378ML327
A17009-5ML327 5mg
A17009-100ML327 100mg
A17009-1ML327 1mg
A17009-10ML327 10mg
A17009-25ML327 25mg
A17009-50ML327 50mg
A17009-10mM-DML327 10mM * 1mL in DMSO

Popular Products